Who owns LONGBOARD PHARMACEUTICALS IN?
- Ticker: LBPH
- CUSIP Number: 54300n103
Tip: Access positions for across all investors
Analyze quarterly positions in Longboard Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Longboard Pharmaceuticals In stock
Who bought or sold LONGBOARD PHARMACEUTICALS IN this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
FMR | 4.5M | $98M | 114% | Mar 2024 |
|
Cormorant Asset Management | 3.4M | $72M | 42% | Mar 2024 |
|
RA Capital Management | 3.3M | $71M | 100% | Mar 2024 |
|
Farallon Capital Management | 2.9M | $64M | 100% | Mar 2024 |
|
T. Rowe Price Associates | 2.2M | $48M | 36% | Mar 2024 |
|
BlackRock | 1.9M | $40M | 137% | Mar 2024 |
|
Vanguard Group | 1.7M | $37M | 119% | Mar 2024 |
|
Point72 Asset Management | 1.4M | $30M | 67% | Mar 2024 |
|
Viking Global Investors | 981k | $21M | 100% | Mar 2024 |
|
Integral Health Asset Management | 975k | $21M | 28% | Mar 2024 |
|
Jennison Associates | 942k | $20M | 96% | Mar 2024 |
|
Parkman Healthcare Partners | 693k | $15M | 95% | Mar 2024 |
|
Pictet Asset Management Holding SA | 577k | $13M | 100% | Mar 2024 |
|
Marshall Wace | 567k | $12M | 100% | Mar 2024 |
|
Geode Capital Management | 556k | $12M | 68% | Mar 2024 |
|
Millennium Management | 533k | $12M | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 505k | $11M | -6% | Mar 2024 |
|
Goldman Sachs Group | 480k | $10M | 3403% | Mar 2024 |
|
Lord, Abbett & Co | 475k | $10M | 100% | Mar 2024 |
|
CIBC Global Asset Management | 342k | $7.4M | 137% | Mar 2024 |
|
American Century Companies | 280k | $6.0M | 100% | Mar 2024 |
|
Schonfeld Strategic Advisors | 233k | $5.0M | 152% | Mar 2024 |
|
Northern Trust | 219k | $4.7M | 60% | Mar 2024 |
|
AWM Investment Company | 212k | $4.6M | 100% | Mar 2024 |
|
Walleye Trading Advisors | 198k | $4.3M | 404% | Mar 2024 |
|
Alyeska Investment Group | 188k | $4.1M | 100% | Mar 2024 |
|
Altium Capital Management | 170k | $3.7M | 100% | Mar 2024 |
|
Eudaimonia Asset Management | 157k | $3.4M | 100% | Mar 2024 |
|
Citadel Advisors | 155k | $3.4M | 100% | Mar 2024 |
|
TD Asset Management | 141k | $3.0M | 50% | Mar 2024 |
|
Nuveen Asset Management | 140k | $3.0M | 541% | Mar 2024 |
|
Platinum Investment Mangement | 127k | $2.7M | 100% | Mar 2024 |
|
J. Goldman & Co | 116k | $2.5M | 100% | Mar 2024 |
|
Two Sigma Investments | 107k | $2.3M | 100% | Mar 2024 |
|
Monashee Investment Management | 100k | $2.2M | 100% | Mar 2024 |
|
Bank of America Corporation | 91k | $2.0M | 393% | Mar 2024 |
|
Morgan Stanley | 84k | $1.8M | 1083% | Mar 2024 |
|
Woodline Partners | 81k | $1.7M | 0% | Mar 2024 |
|
Susquehanna International | 76k | $1.6M | 100% | Mar 2024 |
|
Bridgeway Capital Management | 70k | $1.5M | 40% | Mar 2024 |
|
Bank of New York Mellon | 69k | $1.5M | 51% | Mar 2024 |
|
Laurion Capital Management | 69k | $1.5M | 213% | Mar 2024 |
|
Charles Schwab Investment Management | 68k | $1.5M | 58% | Mar 2024 |
|
Qube Research & Technologies | 55k | $1.2M | 100% | Mar 2024 |
|
UBS O'Connor | 54k | $1.2M | 100% | Mar 2024 |
|
Swiss National Bank | 42k | $914k | 100% | Mar 2024 |
|
ExodusPoint Capital Management | 41k | $889k | 100% | Mar 2024 |
|
UBS Group | 39k | $845k | 157% | Mar 2024 |
|
Ing Investment Management | 36k | $768k | 100% | Mar 2024 |
|
Advisor Group Holdings | 34k | $728k | 100% | Mar 2024 |
|
Rhumbline Advisers | 30k | $648k | 85% | Mar 2024 |
|
Barclays | 30k | $638k | 38% | Mar 2024 |
|
Credit Suisse | 25k | $541k | 100% | Mar 2024 |
|
Jacobs Levy Equity Management | 24k | $515k | 0% | Mar 2024 |
|
Cubist Systematic Strategies | 23k | $496k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 22k | $470k | 533% | Mar 2024 |
|
Legal & General Group | 21k | $442k | 1125% | Mar 2024 |
|
Dimensional Fund Advisors | 20k | $431k | -39% | Mar 2024 |
|
Sei Investments | 20k | $429k | 100% | Mar 2024 |
|
GSA Capital Partners | 19k | $413k | 100% | Mar 2024 |
|
Jane Street | 19k | $400k | 100% | Mar 2024 |
|
State of Wisconsin Investment Board | 16k | $342k | 100% | Mar 2024 |
|
Shay Capital | 15k | $324k | 100% | Mar 2024 |
|
Quantbot Technologies | 14k | $310k | 100% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 11k | $242k | 100% | Mar 2024 |
|
Squarepoint Ops | 11k | $231k | 100% | Mar 2024 |
|
Citigroup | 10k | $218k | 348% | Mar 2024 |
|
New York State Common Retirement Fund | 10k | $215k | -17% | Mar 2024 |
|
Deerfield Management Company | 9.6k | $208k | 100% | Mar 2024 |
|
Ameriprise Financial | 9.5k | $206k | 100% | Mar 2024 |
|
Denali Advisors | 9.3k | $201k | 100% | Mar 2024 |
|
Wells Fargo & Company | 8.4k | $180k | 84% | Mar 2024 |
|
American International | 7.7k | $47k | 0% | Dec 2023 |
|
SG Americas Securities | 6.1k | $132k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 4.6k | $99k | 472% | Mar 2024 |
|
Summit Investment Advisors | 2.5k | $54k | 93% | Mar 2024 |
|
Simplex Trading | 1.7k | $36k | 100% | Mar 2024 |
|
Point72 | 1.6k | $34k | 100% | Mar 2024 |
|
Amalgamated Bank | 841.00 | $18k | -49% | Mar 2024 |
|
Royal Bank of Canada | 569.00 | $0 | -89% | Mar 2024 |
|
Ikarian Capital | 236.00 | $5.1k | -100% | Mar 2024 |
|
LifeSteps Financial | 200.00 | $4.3k | 100% | Mar 2024 |
|
Tower Research Capital | 127.00 | $2.7k | -97% | Mar 2024 |
|
GAMMA Investing | 72.00 | $1.6k | 100% | Mar 2024 |
|
Pnc Financial Services | 40.00 | $864.000000 | 100% | Mar 2024 |
|
Russell Investments | 20.00 | $432.000000 | 100% | Mar 2024 |
|
NISA Investment Advisors | 8.00 | $173.000000 | 100% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $43.000000 | 100% | Mar 2024 |
|
Who sold out of Longboard Pharmaceuticals In?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Prosight Management | Sep 2023 | 321k | $1.8M |
Boothbay Fund Management | Sep 2023 | 113k | $626k |
Bourgeon Capital Management | Dec 2023 | 7.0k | $42k |
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | Dec 2023 | 3.2k | $19k |
Dorsey Wright & Associates | Sep 2023 | 3.0k | $17k |